Definium Therapeutics, Inc.: common_shares_issued
| Value | {"unit": "shares", "value": 37541115, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2022-09-30) |
| Status | current |
| Entity | Definium Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8cf55a26-9c70-4727-a748-e6cc4e6e1b3e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-024192 · Open the official SEC filing →Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001813814/common-shares-issued/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8cf55a26-9c70-4727-a748-e6cc4e6e1b3e
History
- no predecessors — first report